Skip to main content


Press Releases

LAVVAN Appoints Neil Closner as Chief Executive...

Former MedReleaf executive team joins Closner in transformative venture to drive cannabinoid fermentation efforts NEW YORK, NY – August 8, 2019: LAVVAN Inc. (“LAVVAN”) today announced that Neil Closner, formerly […]
Press Releases

Amyris Finalizes Cannabinoid Development, Licensing and Commercialization...

LAVVAN Cites Amyris’s Proven Commercial Achievements and Capability to Bring to Market the Highest Quality Cannabinoids for Large Scale Use EMERYVILLE, Calif., March 18, 2019 (GLOBE NEWSWIRE) — Amyris, Inc. […]
Request Submitted
Thank you for your interest in LAVVAN!

A representative will contact you shortly.

Return To Page

Talk to Us